“We are prepared for a shift to the commercial market in the U.S. for COVID boosters, where the market will be more fragmented than it was during the pandemic,” said Arpa Garay, Moderna’s chief commercial officer.
The Department of Health and Human Services is expected to hold a meeting later this month with drug makers, pharmacies, and state health departments to discuss moving coverage of pandemic therapies away from the U.S. government and into a commercial market, according to The Wall Street Journal.
“We are prepared for a shift to the commercial market in the U.S. for COVID boosters, where the market will be more fragmented than it was during the pandemic, where the U.S. government was the sole purchaser of vaccines,” she said. “All of these are things that actually Pfizer does and the commercial organization of Pfizer does really well. This is our sweet spot,” Angela Hwang, Pfizer’s group president of biopharmaceuticals, said in July during an earnings call. “We look forward to building on top of what the government has been doing, which has been really excellent, and building on top of that to do more and to support greater initiatives across the country.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Covid Deaths: Helping Children Who Lost a Parent to Covid-19More than 200,000 U.S. children and teens have lost a parent or other in-home caregiver to COVID-19. While losing a parent is always very hard for children, COVID has layers to it that can make healing even harder. What will help these children move forward?
Weiterlesen »
COVID Can Disturb Mental and Brain Health Even Two Years After InfectionThe biggest takeaway from a new study is that neurological and psychiatric symptoms from COVID can linger for at least two years after infection in some people.
Weiterlesen »
COVID increases risks of brain fog and dementia 2 years on from infection, study suggestsAnxiety and depression are also more common after COVID, though tend to subside after a couple month, study finds.
Weiterlesen »
Omicron-Specific Booster Expected to Be Available in ‘a Few' Weeks, COVID Czar SaysWhite House COVID coordinator Dr. Ashish Jha said on Wednesday that the newly updated COVID-19 boosters will be available to teens and adults 'in a few short weeks.'
Weiterlesen »
Other Viruses Offer Hints Toward the Mystery of Long COVIDResearchers are chasing a range of potential culprits in the race to find the causes of long COVID. Some things they agree on: There will be a number of different causes, and the symptoms will vary wildly from case to case.
Weiterlesen »